Related Experiment Video
Updated: May 14, 2026
08:46
Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
Published on: September 16, 2021
Fertility preservation: current prospects and future challenges.
1Pôle de Recherche en Gynécologie, Institut de Recherche Expérimentale et Clinique (IREC), Université Catholique de Louvain (UCL), Brussels, Belgium. Christine.wyns@uclouvain.be
Summary
Cancer treatments improve survival but can harm fertility. This review explores fertility restoration from cryopreserved germ cells or gonadal tissue for young patients undergoing gonadotoxic therapies.
Area of Science:
- Reproductive Medicine
- Oncology
Background:
- Cancer therapies and treatments for non-malignant disorders can cause infertility.
- Improved survival rates in pediatric and reproductive-age male patients undergoing gonadotoxic treatments necessitate fertility preservation strategies.
- Fertility impairment affects both pre- and post-pubertal patients.
Purpose of the Study:
- To review current concepts and perspectives on restoring fertility in patients treated with gonadotoxic therapies.
- To examine methods for restoring fertility using cryopreserved germ cells or gonadal tissue.
- To explore the potential of alternative stem cell sources for fertility restoration in research settings.
Main Methods:
- Review of current scientific literature on fertility preservation and restoration.
- Analysis of techniques for utilizing cryopreserved germ cells and gonadal tissue.
- Examination of research on alternative stem cell sources for fertility.
Main Results:
- Cryopreservation of germ cells and gonadal tissue offers viable fertility preservation options prior to gonadotoxic therapy.
- Restoration of fertility is possible through established methods using stored biological materials.
- Research into alternative stem cell sources shows promise for future fertility restoration.
Conclusions:
- Fertility preservation and restoration are critical components of care for young individuals undergoing gonadotoxic treatments.
- Broader clinical implementation of fertility preservation options is needed.
- Ongoing research into stem cell-based fertility restoration holds future potential.
Related Concept Videos
01:28Infertility in Females
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of endometrial...
Endometriosis, a condition characterized by abnormal growth of endometrial...
01:23Infertility in Males
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
01:24In Vitro Fertilization
In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
01:57Meiosis II
Meiosis II is the second and final stage of meiosis. It relies on the haploid cells produced during meiosis I, each of which contain only 23 chromosomes—one from each homologous initial pair. Importantly, each chromosome in these cells is composed of two joined copies, and when these cells enter meiosis II, the goal is to separate such sister chromatids using the same microtubule-based network employed in other division processes. The result of meiosis II is two haploid cells, each containing...
01:38Fertilization
During fertilization, an egg and sperm cell fuse to create a new diploid structure. In humans, the process occurs once the egg has been released from the ovary, and travels into the fallopian tubes. The process requires several key steps: 1) sperm present in the genital tract must locate the egg; 2) once there, sperm need to release enzymes to help them burrow through the protective zona pellucida of the egg; and 3) the membranes of a single sperm cell and egg must fuse, with the sperm...
01:27Reproductive Cloning
Reproductive cloning is the process of producing a genetically identical copy—a clone—of an entire organism. While clones can be produced by splitting an early embryo—similar to what happens naturally with identical twins—cloning of adult animals is usually done by a process called somatic cell nuclear transfer (SCNT).
Somatic Cell Nuclear Transfer
In SCNT, an egg cell is taken from an animal and its nucleus is removed, creating an enucleated egg. Then a somatic cell—any cell that is not a sex...
Somatic Cell Nuclear Transfer
In SCNT, an egg cell is taken from an animal and its nucleus is removed, creating an enucleated egg. Then a somatic cell—any cell that is not a sex...